DrugPatentWatch Database Preview
Secura Company Profile
» See Plans and Pricing
What is the competitive landscape for SECURA, and what generic alternatives to SECURA drugs are available?
SECURA has two approved drugs.
There are nine US patents protecting SECURA drugs.
There are two hundred and thirty-eight patent family members on SECURA drugs in fifty-one countries and fifteen supplementary protection certificates in thirteen countries.
Summary for Secura
| International Patents: | 238 |
| US Patents: | 9 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Secura
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-001 | Feb 23, 2015 | RX | Yes | No | 7,067,551 | Start Trial | Start Trial | ||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-002 | Feb 23, 2015 | RX | Yes | No | 7,067,551 | Start Trial | Start Trial | ||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-003 | Feb 23, 2015 | RX | Yes | Yes | 8,883,842 | Start Trial | Start Trial | ||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-003 | Feb 23, 2015 | RX | Yes | Yes | 6,833,384 | Start Trial | Y | Y | Start Trial | ||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-002 | Feb 23, 2015 | RX | Yes | No | 8,883,842 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Secura Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 206788 | Start Trial |
| Japan | 2017061547 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2007019116 | Start Trial |
| Israel | 243932 | Start Trial |
| Poland | 361408 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Secura Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1318980 | C01318980/01 | Switzerland | Start Trial | PRODUCT NAME: PANOBINOSTAT; REGISTRATION NO/DATE: SWISSMEDIC 61878 23.12.2015 |
| 1912640 | PA2016003 | Lithuania | Start Trial | PRODUCT NAME: PANOBINOSTATAS; REGISTRATION NO/DATE: EU/1/15/1023 20120828 |
| 1318980 | 15C0086 | France | Start Trial | PRODUCT NAME: PANOBINOSTAT OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/15/1023 20150901 |
| 1912640 | PA2016003,C1912640 | Lithuania | Start Trial | PRODUCT NAME: PANOBINOSTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/15/1023 20120828 |
| 1912640 | C20160001 00181 | Estonia | Start Trial | PRODUCT NAME: PANOBINOSTAAT;REG NO/DATE: EU/1/15/1023 01.09.2015 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
